LAS VEGAS, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the Company will be reporting its increased gold and silver production and gross profit for the period ending September 30th, as gold and silver forecasts continue to rise. Additionally, the Company has recently reviewed its substantial gold and silver holdings and their significant appreciation from the initial production values. Further details and the third quarter financial ...

RESTON, Va., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Comscore (NASDAQ: SCOR), a global leader in measuring and analyzing consumer behavior, today announced a partnership with Polaris I/O, a company that offers pipeline as a service solution to enterprise, multi-market and local media sales teams. This collaboration connects Comscore’s audience measurement data and research with the Polaris I/O MarketView solution, enabling media sellers to accelerate the prospecting and pitching of new business. MarketView provid ...

Rich Deakin joins QLE Ltd as Senior Vice President and Managing Director UK Strategic Projects, bringing significant nuclear industry experienceWASHINGTON, Nov. 05, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the production of isotopes for multiple industries, today announced a regulatory progress update in its initiative to produce High-Assay Low Enriched Uranium (“HALEU”) in ...

Company to hold a conference call at 8:00 a.m. ETDURHAM, N.C., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (“Pelthos”), will hold a conference call on Thursday, November 13, 2025, at 8:00 a.m. Eastern Time to discuss its results for the third quarter period ended September 30, 2025. The financial results will be issued in a press release prior to the call. P ...

A collaboration that turns everyday travel into a moment of luxurious self-careNEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- XWELL (Nasdaq: XWEL) (“XWELL” or the “Company”), a leader in wellness solutions for people on the go, today announced they are teaming up with Ostrichpillow – the masters of mindful rest – to launch a co-branded, limited-edition Eye Mask in XWELL's Blue Breeze colorway. Built for function and a touch of everyday luxury, this exclusive collab celebrates both brands' shared mission to mak ...

Empowering travel professionals and paving the way for broader integrationNEW YORK, NY, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Guardforce AI Co., Limited (“Guardforce AI” or the “Company”) (NASDAQ: GFAI, GFAIW), an AI-driven technology company providing smart solutions in automation, robotics, Agentic AI and secured logistics, today announced the launch of DVGO Beta 2.0, marking a major milestone in its AI-first product roadmap and the start of its marketing expansion. DVGO, Guardforce AI’s first travel plannin ...

Conference call today at 9:00 am ETQ3 2025 revenues of $82.1M, +17% v. Q3 2024YTD 2025 revenues of $237.0M, +14% v. YTD 2024Completed acquisition of scPharmaceuticals on October 7, accelerating MannKind’s revenue growth with FUROSCIX®Program updates: sBLA for Afrezza® in pediatric population accepted for FDA review; PDUFA date of May 29, 2026FUROSCIX ReadyFlow™ Autoinjector sNDA submitted to the FDA MNKD-101 NTM global Phase 3 trial (ICoN-1) achieved interim enrollment target ahead of schedule MNKD-201 IPF ...

SOUTH SAN FRANCISCO, Calif, Nov. 05, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (OTC PINK: CERO) (“CERo” or the “Company”), an innovative cellular immunotherapy company pursuing new targets and novel phagocytic mechanisms, announces the initiation of the second cohort of its Phase 1 CER-1236 clinical trial focused on patients with acute myeloid leukemia (AML). The first patient in the cohort (the fourth patient in the trial) received an initial dose of CER-1236 at twice the initial dose of t ...

-- Milestone advances two-part study evaluating novel, locally administered gene therapy designed to increase anti-inflammatory IL-1Ra production in the knee joint -- BRISBANE, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it has concluded patient enrollment in Part A of its Phase 2 ASCEND study evaluating PCRX-201 (enekinragene ...

Quanzhou, China, Nov. 05, 2025 (GLOBE NEWSWIRE) -- INLIF LIMITED (Nasdaq: INLF) (the “Company” or “INLIF”), a company engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms, today announced the official commencement of Phase II construction of its digital intelligent manufacturing base project (the “Project”) in Nan’an city, Fujian Province. The groundbreaking ceremony was attended by Mr. Wang Lianzan, Mayor of Nan’an City, underscoring the sig ...